People who qualify will receive Ozempic at no cost
Many studies indicate that MCH1R antagonists modulate energy homeostasis and thus, the anti-obesity effects are due primarily to increased energy expenditure and not to suppression of feeding behaviors
Because GLP-1s slow gastric emptying and reduce appetite, users often eat smaller meals, feel full earlier, and gradually reduce weightoften more quickly than lifestyle changes alone
Before making any changes to your treatment plan, consider these key points: Theyre not for everyone
After 17 years of GLP1RA use in humans there is no MTC signal One ongoing mystery in the GLP-1 space is @US_FDA perpetuation of the black box warning for MTC, in the absence of any scientific evidence that this is warranted
Employer advocacy For those on employer-sponsored plans, talking to your HR department about adding weight management drug coverage can make a difference, especially if multiple employees are interested